期刊文献+

不同方式注射曲安奈德治疗黄斑水肿的眼压变化观察 被引量:1

Changes of intraocular pressure after intravitreal injection and posterior sub-tenon injection of triamcinolone acetonide the treatment of macular edema
下载PDF
导出
摘要 目的探讨玻璃体腔注射(IVTA)和后Tenon囊下注射(PSTA)治疗黄斑水肿后的眼压变化情况。方法对167例黄斑水肿患者随机分为两组,分别采取IVTA和PSTA治疗,对比观察治疗后的眼压变化情况。结果 PSTA组平均眼压,高眼压发生率及6个月后残留高眼压率均明显低于IVTA组,P<0.05。结论 PSTA在眼压升高方面具有更好的安全性和耐受性。 Objective To compare changes of intraocular pressure(lOP) of intravitrcal injection and posterior sub-tenon injection of triameinolone acetonide on macular edema. Methods 167 patients of 167 eyes with maeuiar edema were randomized into two groups,intravitreal injection of triamcinolone acetonide group (IVTA group) and posterior sub-tenon injection of triamcin- olone aeetonide (PSTA group). Changes of intraocular pressure were compared between the two groups. Results The PSTA group was obviously lower than the IVTA group in the mean IOP, the elevation lOP and tile residual elevation lOP 'after 6 months. There was statistical difference. Conclusion The PSTA group was could be safer and more tolerability, in the elevation IOP.
作者 王涌 吴晓红
出处 《四川医学》 CAS 2012年第12期2123-2124,共2页 Sichuan Medical Journal
关键词 曲安奈德 玻璃体腔注射(IVTA) 后Tenon囊下注射(PSTA) 眼压 triamcinolone acetonide intravitreal injection posterior sub-tenon injection intraocular pressure
  • 相关文献

参考文献4

二级参考文献42

  • 1王景昭.黄斑水肿的药物和手术治疗[J].中华眼底病杂志,2004,20(5):316-319. 被引量:26
  • 2Antcliff RJ,Spalton DJ,Stanford MR,et al. Intravitreal triamcinolone for uveitic cystoid macular edema:an optical coherence tomography study. Ophthalmology,2001,108: 765-772.
  • 3LashayAR, Rahimi A,Chams H,et al. Evaluation of the effect of acetzolamide on cystoid macular edema in patients with Behcet′s disease. Eye,2003,17:762-766.
  • 4Kobayashi H,Kobayashi K,Okinami S. Randomized clinical trial of topical betaxolol for persistent macular edema after vitrectomy and epiretinal membrane removal. Am J Ophthalmol, 2003,136:244-251.
  • 5Campochiaro PA,The C99-PKC412-003 Study Group. Reduction of diabetic macular edema by oral administration of the kinase inhibitor PKC412. Invest Ophthalmol Vis Sci, 2004,45: 922-931.
  • 6Danis RP,Bingaman DP,Yang Y,et al. Inhibition of preretinal and optic nerve head neovascularization in pig by intravitreal triamcinolone acetonide. Ophthalmol,1996,103: 2099-2104.
  • 7Danis RP,Ciulla TA,Partt LM,et al.Intravitreal triamcinolone acetonide in exudative age-related macular degeneration.Retina,2000,20: 244-250.
  • 8Jonas JB,Kreissig I,Kamppeter B,et al. Intrvitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases. Ophthalmology, 2004,101: 113-120.
  • 9Beer PM,Bakri ST,Singh RT,et al. Intraocular concentration and pharmacokinetics of tramcinolone acetonide after a single intravitreal injection.Ophthalmology, 2003, 110: 681-686.
  • 10Jonas JB. Intraocular availability of triamcinolone acetonide after intravitreal injection. Am J Ophthalmol,2004, 137:560-562.

共引文献82

同被引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部